Cargando…

Choroidal Vascularity Index as a Biomarker for Visual Response to Antivascular Endothelial Growth Factor Treatment in Diabetic Macular Edema

PURPOSE: To investigate the choroidal vascularity index (CVI) as a prognostic factor for the visual efficacy of antivascular endothelial growth factor (VEGF) treatment in diabetic macular edema (DME). METHODS: We retrospectively reviewed 92 DME eyes receiving anti-VEGF treatment, which were stratifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dou, Ningxin, Yu, Shanshan, Tsui, Ching-Kit, Yang, Boyu, Lin, Jianqiang, Lu, Xi, Xu, Yue, Wu, Benjuan, Zhao, Jinfeng, Liang, Xiaoling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642029/ https://www.ncbi.nlm.nih.gov/pubmed/34869776 http://dx.doi.org/10.1155/2021/3033219

Ejemplares similares

Use of antivascular endothelial growth factor for diabetic macular edema
por: Karim, Rushmia, et al.
Publicado: (2010)

Combined argon laser photocoagulation and antivascular endothelial growth factor for management of macular polypoidal choroidal vasculopathy
por: Sen, Parveen, et al.
Publicado: (2016)

Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
por: Mansour, Ahmad M., et al.
Publicado: (2014)

Antivascular Endothelial Growth Factor Dosing Frequency and Visual Outcomes in Macular Edema Following Central Retinal Vein Occlusion
por: Modi, Yasha S., et al.
Publicado: (2021)

Role of the choroidal vascularity index in branch retinal vein occlusion (BRVO) with macular edema
por: Hwang, Bo-Een, et al.
Publicado: (2021)

Changes in Macular Microvascular Structure in Macular Edema Secondary to Branch Retinal Vein Occlusion Treated with Antivascular Endothelial Growth Factor for One Year
por: Song, Shuang, et al.
Publicado: (2021)

Predictive factors of better outcomes by monotherapy of an antivascular endothelial growth factor drug, ranibizumab, for diabetic macular edema in clinical practice
por: Sato, Shinri, et al.
Publicado: (2017)

Association between Inflammatory Factors in the Aqueous Humor and Hyperreflective Foci in Patients with Intractable Macular Edema Treated with Antivascular Endothelial Growth Factor
por: Li, Min, et al.
Publicado: (2021)

Antivascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration
por: Zampros, Ilias, et al.
Publicado: (2012)

Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration
por: Tranos, Paris, et al.
Publicado: (2013)

Clinical characteristics and antivascular endothelial growth factor effect of choroidal neovascularization in younger patients in Taiwan
por: Li, Yi-Hsuan, et al.
Publicado: (2015)

Commentary: Ziv-aflibercept: An alternative antivascular endothelial growth factor agent for polypoidal choroidal vasculopathy
por: Anshuman, Kumar, et al.
Publicado: (2019)

Treatment results of diabetic macular edema with different choroidal thickness with intravitreal anti vascular endothelial growth factor
por: Savur, Fatma, et al.
Publicado: (2022)

Antivascular endothelial growth factor for macular oedema secondary to retinal vein occlusion: a systematic review and meta-analysis
por: Xu, Shanshan, et al.
Publicado: (2022)

Longitudinal Assessment of the Choroidal Vascularity Index in Eyes with Branch Retinal Vein Occlusion-Associated Cystoid Macular Edema
por: Pant, Praruj, et al.
Publicado: (2023)

Choroidal Vortex Vein Drainage System in Central Serous Chorioretinopathy Using Ultra-Widefield Optical Coherence Tomography Angiography
por: Luo, Zhonghua, et al.
Publicado: (2023)

Subfoveal choroidal thickness in diabetic macular edema
por: Mohamed, Dalia Mohamed Fawzy, et al.
Publicado: (2019)

Efficacy and safety profile of intravitreal dexamethasone implant versus antivascular endothelial growth factor treatment in diabetic macular edema: a systematic review and meta-analysis
por: Chi, Sheng-Chu, et al.
Publicado: (2023)

Bilateral choroidal neovascularization associated with optic nerve head drusen treated by antivascular endothelial growth factor therapy
por: Delas, Barbara, et al.
Publicado: (2012)

Systematic review with network meta-analysis of antivascular endothelial growth factor use in managing polypoidal choroidal vasculopathy
por: Chi, Sheng-Chu, et al.
Publicado: (2021)

Choroidal vascularity index change in macular telangiectasia type 2
por: Chun, Heejeong, et al.
Publicado: (2022)

Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration
por: Chandra, Shruti, et al.
Publicado: (2020)

Cystoid macular edema as the initial manifestation of choroidal melanoma
por: Garoon, Robert B., et al.
Publicado: (2012)

Choroidal Thickness in Different Patterns of Diabetic Macular Edema
por: Amjad, Rida, et al.
Publicado: (2022)

Intravitreal Ozurdex has no short term influence on choroidal thickness and vascularity index in eyes with diabetic macular edema: A pilot study
por: Rishi, Pukhraj, et al.
Publicado: (2021)

Pars plana vitrectomy combined with internal limiting membrane peeling for recurrent macular edema due to branch retinal vein occlusion after antivascular endothelial growth factor treatments
por: Shirakata, Yukari, et al.
Publicado: (2016)

Anti-vascular endothelial growth factor treatment in diabetic macular edema
por: Kim, Moosang
Publicado: (2016)

Incidence of Acute Endophthalmitis after Intravitreal Antivascular Endothelial Growth Factor Injection in Age-related Macular Degeneration
por: Seong, Hyo Jin, et al.
Publicado: (2022)

Commentary: Antivascular endothelial growth factor and retinopathy of prematurity
por: Dudani, Ajay Indur, et al.
Publicado: (2019)

Treatment of Diabetic Macular Edema with Intravitreal Antivascular Endothelial Growth Factor and Prompt versus Deferred Focal Laser during Long-Term Follow-Up and Identification of Prognostic Retinal Markers
por: Weingessel, Birgit, et al.
Publicado: (2018)

Relationship between diabetic macular edema and choroidal layer thickness
por: Endo, Hiroaki, et al.
Publicado: (2020)

Efficacy and Safety of Antivascular Endothelial Growth Factor (Anti-VEGF) in Treating Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Meta-analysis
por: Yin, Xiaobei, et al.
Publicado: (2022)

ASSOCIATION BETWEEN ANATOMICAL AND CLINICAL OUTCOMES OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED WITH ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR
por: Nguyen, Vuong, et al.
Publicado: (2021)

Anti-vascular endothelial growth factor in the treatment of macular edema in epidemic retinitis
por: Kawali, Ankush A, et al.
Publicado: (2020)

Choroidal Vascularity Index in Different Cohorts of Dry Age-Related Macular Degeneration
por: Sacconi, Riccardo, et al.
Publicado: (2021)

Six-Year Real-World Outcomes of Antivascular Endothelial Growth Factor Monotherapy and Combination Therapy for Various Subtypes of Polypoidal Choroidal Vasculopathy
por: Yang, Jingyuan, et al.
Publicado: (2019)

Spontaneous Resolution of Subretinal Detachment in Choroidal Osteoma Unresponsive to Antivascular Endothelial Growth Factor Agent and Multimodal Imaging: A Case Report
por: Lee, Hyuk Jun, et al.
Publicado: (2023)

Comparison of antivascular endothelial growth factor treatment for myopia choroidal neovascularisation: a systematic review and meta-analysis of randomised controlled trials
por: Dong, Liming, et al.
Publicado: (2023)

Posterior polar annular choroidal dystrophy association with cystoid macular edema
por: Del Valle‐Nava, Fernando, et al.
Publicado: (2019)

Influence of Intravitreal Therapy on Choroidal Thickness in Patients with Diabetic Macular Edema
por: Udaondo Mirete, Patricia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nmarhgo9fqk1jba8f6m65n8bla